STLN
The Oncology Institute, Inc.
6.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +33.1% | +7.0% | +10.5% | |
| – | -35.7% | -37.4% | -59.2% | |
| – | – | +665.5% | -92.7% | |
| – | -17.4% | -17.0% | -15.5% | |
| – | – | – | – | |
| – | -88.7% | -100.0% | – | |
| – | -100.1% | -61.4% | +51,276.9% | |
| – | -107.4% | -49.0% | – | |
| – | – | -16.9% | -199.5% | |
| – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.